Rhumbline Advisers Increases Position in Candel Therapeutics, Inc. (NASDAQ:CADL)
Rhumbline Advisers lifted its holdings in Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) by 26.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 33,302 shares of the company’s stock after acquiring an additional 7,030 shares during the quarter. Rhumbline Advisers’ holdings in Candel Therapeutics were worth $188,000 as of its most recent […]
Rhumbline Advisers lifted its holdings in Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) by 26.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 33,302 shares of the company’s stock after acquiring an additional 7,030 shares during the quarter. Rhumbline Advisers’ holdings in Candel Therapeutics were worth $188,000 as of its most recent […]
